# Developmental Research Program

> **NIH NIH P20** · UNIVERSITY OF CHICAGO · 2020 · $98,208

## Abstract

PROJECT ABSTRACT- Developmental Research Program
The objective of the University of Chicago Cancer Health Disparities P20 SPORE Developmental Research
Program (DRP) is to create a streamlined and transparent mechanism for soliciting and selecting exciting
and novel research projects that have significant potential for translational success. While we view
collaboration on these projects among scientists within and /or outside our Institution as an essential criterion
for success, our primary selection criteria will be innovation, degree of impact on cancer health disparities,
and preferably a multi-disciplinary approach. This program will be co-led by Dr. Lucy Godley, a physician
scientist, co-Director of the Chicago Biomedical Consortium and leader in the field of inherited hematologic
malignancies and track record in translating basic science to improve clinical care, and Dr. Karen Kim, a
gastroenterologist, Associated Director for Community Engagement and Outreach in our Cancer Center and
Director of the Center for Asian Health Equity. Drs. Godley and Kim both have a strong commitment to health
disparities research in African American, Hispanic and Asian populations.
SPECIFIC AIMS OF THE SPORE DEVELOPMENTAL RESEARCH PROGRAM (DRP)
Aim 1: Establish a mechanism for soliciting DRP applications that reaches beyond cancer center members
 and the local P20 SPORE community to all biological, physical, computer, and social science faculty
 members at the U of C and Argonne National Laboratory, as well as to investigators at other SPOREs
nationwide.
Aim 2: Encourage, support, and nurture interdisciplinary collaboration using the expertise of our
 interdisciplinary Internal Scientific Advisory Board.
Aim 3: Select and assess projects that help generate new hypotheses for development as full-fledged
 SPORE projects.
The UChicago P20 SPORE DRP will provide $200,000 annually ($50,000 from SPORE funds and $150,000
from institutional support) to fund four projects. There is a possibility of a second year of support based on
progress. Criteria for selection will be: 1) scientific merit and potential relevance to cancer health disparities;
2) originality; 3) expertise of key personnel; and 4) perceived likelihood of generating peer-reviewed external
grant support to establish further work in preclinical and clinical work relevant to health disparities. The P20
SPORE Executive Committee will work with the Internal Advisory Board to select projects and encourage
successful investigators to pursue independent funding so that even investigators who may be new to cancer
disparities research will have a high likelihood of successful application of their ideas to cancer prevention,
diagnosis, and treatment.

## Key facts

- **NIH application ID:** 9994745
- **Project number:** 5P20CA233307-03
- **Recipient organization:** UNIVERSITY OF CHICAGO
- **Principal Investigator:** LUCY Ann GODLEY
- **Activity code:** P20 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $98,208
- **Award type:** 5
- **Project period:** 2018-09-13 → 2022-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9994745

## Citation

> US National Institutes of Health, RePORTER application 9994745, Developmental Research Program (5P20CA233307-03). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9994745. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*